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OXA-48 beta-lactamase producers are emerging as an 
important threat mostly in the Mediterranean area. We 
report here the molecular epidemiology of a collection 
of OXA-48 beta-lactamase-positive enterobacterial 
isolates (n=107) recovered from European and north-
African countries between January 2001 and December 
2011. This collection included 67 Klebsiella pneumo-
niae, 24 Escherichia coli and 10 Enterobacter cloacae. 
Using the EUCAST breakpoints, ninety-eight isolates 
(91.6%) were of intermediate susceptibility or resist-
ant to ertapenem, whereas 66% remained susceptible 
to imipenem. Seventy-five per cent of the isolates co-
produced an extended-spectrum beta-lactamase, most 
frequently CTX-M-15 (77.5%). Susceptibility testing 
to non-beta-lactam antibiotics showed that colistin, 
tigecycline, amikacin, and fosfomycin remain active 
against most of the isolates. Multilocus sequence typ-
ing indicated that the most common sequence types 
(ST) were ST101 and ST38 for K. pneumoniae and 
E. coli, respectively. The blaOXA-48 gene was located on a 
62 kb IncL/M plasmid in 92.5% of the isolates, indicat-
ing that a single plasmid was mainly responsible for 
the spread of that gene. In addition, this study iden-
tified multiple cases of importation of OXA-48 beta-
lactamase producers at least in Europe, and spread 
of OXA-48 beta-lactamase producers giving rise to an 
endemic situation, at least in France.
Introduction 
Currently, an emergence of carbapenem resistance in 
Enterobacteriaceae is reported, mostly related to the 
spread of carbapenemases [1]. Those carbapenem-
hydrolysing beta-lactamases belong to the Ambler 
class A (e.g. KPC), class B (e.g. IMP, VIM and NDM) 
[1], and class D (e.g. OXA-48 and its variants possess-
ing weaker but significant carbapenemase activity) 
[2]. OXA-48 had first been identified from a clinical 
Klebsiella pneumoniae isolate recovered in Istanbul, 
Turkey, in 2001 [3]. The corresponding gene, namely 
blaOXA-48, was then also identified in Escherichia 
coli and Citrobacter freundii, still in Turkey [4]. For 
several years, OXA-48 was identified only in Turkey, 
and almost all OXA-48 beta-lactamase producers were 
reported from patients hospitalised in Turkey or with 
a link to that country [4,5]. Since 2008, this gene has 
been identified in many other countries, most often in 
 K. pneumoniae isolates [2,5-10]. OXA-48 is now identi-
fied in the Middle East and in North African countries, 
and those countries are considered as reservoirs of 
OXA-48 beta-lactamase producers [2]. In addition to 
sporadic cases, an increasing number of outbreaks 
due to OXA-48-producing K. pneumoniae are currently 
observed, not only in Turkey but also in Belgium, 
France, Greece, the Netherlands and Spain [2,11-13]. 
K. pneumoniae strains belonging to specific sequence 
types (ST), such as ST395 and ST101, have been 
involved in those outbreaks [12,14].
In order to gain further understanding of that phe-
nomenon, our study aimed at comparing the genetic 
features of OXA-48 beta-lactamase-producing strains 
recovered from various countries by analysing an exist-
ing collection of 107 blaOXA-48-positive enterobacterial 
isolates. The genetic context and the location of the 
blaOXA-48 gene were investigated, as well as resistance 




A total of 107 OXA-48 beta-lactamase-producing enter-
obacterial isolates were investigated retrospectively. 
Enterobacteriacae producing OXA-48-like beta-lac-
tamases were not included in this study. All isolates 
had been recovered from clinical specimens except a 
single isolate (one Serratia marcescens strain from an 
environmental water sample in Morocco), and had been 
received between January 2001 and December 2011 in 
our National Reference Laboratory which is also used 
as an International Reference Laboratory by many 
colleagues worldwide who send us their isolates for 
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further characterisation. Of identical strains in an out-
break, only one was included in this work. The distri-
bution of clinical samples was as follows: rectal swabs 
(n=33), urine samples (n=24), blood samples (n=12), 
wound samples (n=7), respiratory specimens (n=4), 
catheters (n=4), bone specimens (n=2), peritoneal flu-
ids (n=2), and placenta specimen (n=1). One sample 
per patient was included. Detailed information could 
not be obtained for 18 clinical samples. The isolates 
were identified to species level using the API 20E sys-
tem (bioMérieux, La Balme-les-Grottes, France). 
Susceptibility testing
Routine antibiograms were determined by disk diffu-
sion method on Mueller-Hinton (MH) agar (Bio-Rad, 
Marnes-la-Coquette, France) and interpreted using the 
guidelines of the Clinical and Laboratory Standards 
Institute (CLSI) (updated 2012) and of the European 
Committee on Antimicrobial Susceptibility Testing 
(EUCAST) for tigecycline and colistin [15,16]. In addi-
tion, MICs were determined for imipenem, meropenem, 
ertapenem, cefotaxime, and ceftazidime using E-test 
(bioMérieux, La Balme-les-Grottes, France). The pro-
duction of extended-spectrum beta-lactamases (ESBL) 
was evidenced by a double-disk synergy test per-
formed with cefepime, ceftazidime, and ticarcillin/cla-
vulanic acid disks [17] and more recently by using the 
rapid ESBL NDP test [18].
PCR and sequencing of beta-
lactamase-encoding genes
Whole-cell DNA was extracted using the QiaAmp DNA 
minikit and following the manufacturer’s recommenda-
tions (Qiagen, Courtaboeuf, France). All isolates were 
screened by PCR for the Ambler class A and B carbap-
enemase-encoding genes blaKPC, blaIMP, blaVIM, blaNDM 
[19-20]. For each isolate, the blaOXA-48 gene was ampli-
fied using primers preOXA-48A and preOXA-48B, and 
subsequently sequenced [21]. Detection of other beta-
lactamase genes such as blaTEM, blaSHV, blaCTX-M, blaAmpC-
like, and blaOXA-1 was performed with internal primers, 
as described previously [19,22]. PCR products were 
analysed on agarose gel and sequenced by using the 
amplification primers with an automated sequencer 
(ABI PRISM 3100; Applied Biosystems). The nucleotide 
and deduced protein sequences were analysed using 
software from the National Center for Biotechnology 
Information (www.ncbi.nlm.nih.gov).
Strain typing
Multilocus sequence typing (MLST) with seven house-
keeping genes (rpoB, gapA, mdh, pgi, phoE, infB 
and tonB) was performed for K. pneumoniae isolates 
according to Diancourt et al. [23]. Allele sequences and 
STs were verified at http://pubmlst.org/Kpneumoniae. 
Fragments of seven housekeeping genes (adk, fumC, 
gyrB, icd, mdh, purA and recA) were amplified and 
sequenced for E. coli isolates as described on the 
following website http://mlst.ucc.ie/mlst/dbs/Ecoli. 
A different allele number was given to each distinct 
sequence within a locus, and a distinct ST number 
was attributed to each distinct combination of alleles. 
E. coli isolates were assigned to the major E. coli phy-
logenetic groups (A, B1, B2, and D) by multiplex PCR, 
as described [24]. The genetic relationship between 
the Enterobacter cloacae isolates was studied using 
Diversilab, a semi-automated typing system based on 
repetitive sequence-based PCR (rep-PCR) following the 
manufacturer’s instructions (bioMérieux). 
Plasmid DNA analysis, transformation 
and mating-out assays
Plasmid DNA was extracted from the isolates using 
the Kieser technique [25]. E. coli NCTC50192, harbour-
ing four plasmids of 154, 66, 48 and 7 kb, was used as 
plasmid size marker. Plasmid DNAs were analysed by 
agarose gel electrophoresis. Direct transfer of the car-
bapenem resistance markers was attempted by liquid 
mating-out assays at 37°C, using E. coli J53 as recipi-
ent, or by electrotransformation of plasmid DNA, using 
E. coli TOP10 as recipient as reported [3,4]. Selection 
was performed on agar plates supplemented with 
ertapenem (0.5 µg/ml) and azide (100 µg/ml) for mat-
ing-out assays. In order to search for a possible chro-
mosomal location of the blaOXA-48 gene in E. coli isolates 
19 to 24, restriction with endonuclease I-CeuI followed 
by pulsed-field gel electrophoresis (PFGE) analysis was 
performed as described [26]. 
Replicon and transposon typing
PCR-based replicon typing (PBRT) of the main plasmid 
incompatibility groups reported in Enterobacteriaceae 
was performed as described [27] and using the spe-
cific primers designed from plasmid pOXA-48a [28]. 
Genetic structures surrounding the blaOXA-48 gene were 
determined according to the Tn1999-like PCR-mapping 
scheme as described [29].
Results
Bacterial isolates
A total of 107 isolates were studied, including K. 
pneumoniae (n=67), E. coli (n=24), and E. cloacae 
(n=10) (Table 1). Other enterobacterial species were 
identified: Citrobacter koseri (n=2), C. freundii (n=1), 
Klebsiella oxytoca (n=1), Providencia rettgeri (n=1), and 
S. marcescens (n=1). They had been isolated in France 
(n=61), Morocco (n=22), Turkey (n=11), Egypt (n=3), 
Lebanon (n=2), Tunisia (n=2), Switzerland (n=2), South 
Africa (n=2), Belgium (n=1), and the Netherlands (n=1), 
respectively (Table 1). Among the 61 strains collected 
in France, 30 had a history of international travel to 
the following countries: Morocco (n=14), Tunisia (n=2), 
Libya (n=5), Algeria (n=4), Egypt (n=3), Senegal (n=1), 
and Kuwait (n=1). In 12 cases, no travel history from 
a foreign country was identified. For the remaining 19 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Susceptibility to carbapenems and 
broad-spectrum cephalosporins
Results of susceptibility testing are shown in Tables 
2 and 3. According to the CLSI guidelines, 40 (60%) 
K. pneumoniae isolates, 20 (83%) E. coli isolates, and 
10 (100%) E. cloacae isolates were susceptible to imi-
penem (Table 2). In addition, 40 (60%) K. pneumoniae, 
21 (88%) E. coli, and 9 (90%) E. cloacae isolates were 
susceptible to meropenem. By contrast, 62 (92%) 
K. pneumoniae, 20 (83%) E. coli, and 10 (100%) E. 
cloacae isolates were found of intermediate suscep-
tibility or resistant to ertapenem (Table 2). Regarding 
the broad-spectrum cephalosporins, 73 (68%) and 90 
(84%) isolates were resistant or of intermediate sus-
ceptibility to ceftazidime and cefotaxime, respectively 
(Table 1 and 3).
Beta-lactamase genes
Among the 107 OXA-48-producing isolates, 80 (75%) 
co-produced an ESBL. A blaCTX-M-like gene was detected 
in 71 (66%) of the isolates (89% of the ESBL-producing 
isolates). Among the different CTX-M variants iden-
tified, those belonging to the CTX-M-1 and CTX-M-9 
groups accounted for 87.5% (n=62) and 12.5% (n=9), 
respectively. CTX-M-15 was the only representa-
tive of the CTX-M-1 group. In the CTX-M-9 group, the 
blaCTX-M-14 was identified in a single E. coli (Table 1). Two 
E. cloacae isolates harboured a blaCTX-M-9 gene and 6 
E. coli isolates harboured a blaCTX-M-24 gene. The other 
ESBL determinants were SHV-2a (one K. pneumoniae), 
SHV-12 (three K. pneumoniae, two E. cloacae, and one 
C. freundii), SHV-27 (one K. pneumoniae) and TEM-101 
(P. rettgeri isolate no. 15). Among the SHV-12-producing 
isolates, one E. cloacae co-produced CTX-M-9 (Table 1). 
In addition, a novel VEB variant, namely VEB-8, was 
identified in a single E. coli isolate from Libya that 
co-produced CMY-2 (E. coli 18). VEB-8 differed from 
VEB-5 by a single amino acid substitution (GenBank 
accession number JX679208) [30,31]. It is interesting to 
note that ESBLs were not related to date or geographic 
area of isolation.
Furthermore, nine isolates (8.5%) co-produced a plas-
mid-mediated AmpC-type beta-lactamase. Four isolates 
(3.8%) produced a CMY-type beta-lactamase, namely 
CMY-4 in a single E. coli isolate from Egypt and CMY-2 
in three isolates (a single E. coli and two K. pneumo-
niae isolates from Libya). Five isolates (5%) produced 
a DHA-like AmpC, namely DHA-1 in three K. pneumo-
niae isolates and DHA-7 in two E. cloacae isolates. All 
the DHA-producing isolates originated from Morocco. A 
single isolate (E. coli 29 from Egypt) co-produced OXA-
48 and another carbapenemase, namely VIM-1, in addi-
tion to CMY-4. The non-ESBL beta-lactamases TEM-1 
and OXA-1 were detected in 79 (74%) and 47 (44%) iso-
lates, respectively.
Susceptibility to non-beta-lactam antibiotics
Results of susceptibility testing for non-beta-lactam 
antibiotics are shown in Table 3. Four antibiotics were 
active against the majority of the isolates; 104 (99%) of 
the 107 isolates were susceptible to colistin, 90 (84.1%) 
to tigecycline, 83 (77.6%) to amikacin, and 77 (72%) to 
fosfomycin. Conversely, 84 (78.5%) of the 107 isolates 
were resistant to sulfamethoxazole-trimethoprim, 72 
(67.3%) to tetracycline, 64 (59.8%) to ciprofloxacin, 
and 61 (57%) to gentamicin. Resistant isolates that pro-
duced an ESBL were mostly resistant also to non-beta-
lactam antibiotics (Table 3). 
Table 2
Susceptibility to carbapenems of Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae isolates, 2001–11 (n=107)
Species Antimicrobial drug
Susceptibility
Number (%) of isolates
Susceptible Intermediate Resistant
K. pneumoniae (n=67)
Imipenem 40 (60) 13 (19) 14 (21)
Ertapenem 5 (7) 9 (13) 53 (79)
Meropenem 40 (60) 6 (9) 21 (31)
E. coli (n=24)
Imipenem 20 (84) 3 (12) 1 (4)
Ertapenem 4 (17) 8 (33) 12 (50)
Meropenem 21 (88) 0 (0) 3 (12)
E. cloacae (n=10)
Imipenem 10 (100) 0 (0) 0 (0)
Ertapenem 0 (0) 3 (30) 7 (70)
Meropenem 9 (90) 1 (10) 0 (0)
 
The percentages are rounded so as to add up to 100%.
The results in this Table are from E-tests.
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Phylogenetic groups of the 
Escherichia coli isolates
More than half of E. coli isolates belonged to the phylo-
genetic group D (14 of the 24 E. coli isolates), seven E. 
coli isolates belonged to the phylogenetic group A, two 
belonged to the phylogenetic group B2, and one iso-
late belonged to the phylogenetic group B1 (Table 1).
Mulilocus sequence typing
The distribution of the sequence types among the 
K. pneumoniae and E. coli isolates is shown in Figures 
1 and 2, respectively. ST101 was the most commonly 
observed ST for the K. pneumoniae isolates, account-
ing for 17 out of 67 isolates (25.4%), followed by ST395 
and ST15 (7 isolates, 10.5%) (Figure 1). Six isolates 
(9%) belonged to ST147 (9%) and the other isolates to 
diverse STs, namely ST14 (n=4), ST45 (n=4), ST25 (n=2), 
ST392 (n=2), and one to other STs (Figure 1). Among the 
24 OXA-48-positive E. coli isolates, seven belonged to 
ST38 (29.2%). The remaining 17 isolates belonged to 
STs 10, 617, 648 and 2969 (two isolates each) and to 
STs 46, 69, 95, 101, 362, 410, 746, 963 and 1092 (one 
isolate each) (Figure 2).
Since no MLST system has been developed for typing 
the E. cloacae species, these isolates were genotyped 
using the DiversiLab method. E. cloacae 7 and 9 recov-
ered from Morocco were closely related, and E. cloacae 
1, 2 and 5 (also from Morocco) belonged to the same 
cluster. The other E. cloacae isolates were distinct 
(data not shown). 
Genetic location the blaOXA-48 gene
Using the specific primers designed from the refer-
ence plasmid pOXA-48a of K. pneumoniae 11978 [27] 
to amplify its replicase gene, 99 of the 107 isolates 
(92.5%) carried an IncL/M-pOXA-48a-like backbone. 
For the eight other isolates (P. rettgeri isolate no. 15, 
E. coli isolates no. 19 to 24, and E. coli isolate no. 
37), mating-out assays were performed and transcon-
jugants harbouring the blaOXA-48 gene were obtained 
for P. rettgeri isolate no. 15 and E. coli isolate no. 37. 
Plasmid DNA analysis of the two E. coli transconjugants 
revealed a single plasmid. Those two blaOXA-48-positive 
plasmids corresponded to a ca. 150 kb IncA/C-type 
plasmid identified from P. rettgeri isolate no. 15 from 
Turkey and a ca. 160-kb IncF-type plasmid from an E. 
coli isolate from France. Despite repeated attempts, 
transconjugants or transformants were not obtained 
for six of the seven E. coli isolates belonging to ST38. 
Interestingly, I-CeuI analysis confirmed the chromo-
somal location of the blaOXA-48 gene in those six isolates 
(data not shown). Furthermore, one out of the seven 
blaOXA-48-positive ST38 E. coli harboured the epidemic 
OXA-48 IncL/M-type plasmid. 
Genetic environment of the blaOXA-48 gene
The blaOXA-48 gene was flanked by two copies of IS1999. 
In 21 isolates (19.6%), the upstream copy remained 
intact. This structure corresponded to transposon 
Tn1999, whereas 84 isolates (78.5%) had a Tn1999.2 
transposon structure in which the IS1999 is disrupted 
by insertion of an IS1R element [4]. In two isolates 
Table 3




Number (%) of isolates
Susceptible Intermediate Resistant
Total ESBL Non-ESBL Total ESBL Non-ESBL Total ESBL Non-ESBL
Ceftazidime 34 (31.8) 10 (9.4) 24 (22.4) 9 (8.4) 7 (6.5) 2 (1.9) 64 (59.8) 63 (58.9) 1 (0.9)
Cefotaxime 17 (15.9) 0 (0) 17 (15.9) 8 (7.5) 1 (1.0) 7 (6.5) 82 (76.6) 79 (73.8) 3 (2.8)
Tetracycline 34 (31.8) 21 (19.6) 13 (12.2) 1 (0.9) 1 (0.9) 0 (0) 72 (67.3) 58 (54.2) 14 (13.1)
Tigecycline 90 (84.1) 69 (64.5) 21 (19.6) 5 (4.7) 4 (3.7) 1 (1.0) 12 (11.2) 7 (6.5) 5 (4.7)
Fosfomycin 77 (72.0) 58 (54.2) 19 (17.8) 2 (1.8) 2 (1.8) 0 (0) 28 (26.2) 20 (18.7) 8 (7.5)
Sulfamethoxazol/
trimethoprim 23 (21.5) 7 (6.5) 16 (15.0) 0 (0) 0 (0) 0 (0) 84 (78.5) 73 (68.2) 11 (10.3)
Colistin 104a (99.0) 78 (74.3) 26 (24.7) 0 (0) 0 (0) 0 (0) 1 (1.0) 1 (1.0) 0 (0)
Ciprofloxacin 39 (36.4) 21 (19.6) 18 (16.8) 4 (3.8) 4 (3.8) 0 (0) 64 (59.8) 55 (51.4) 9 (8.4)
Amikacin 83 (77.6) 60 (56.1) 23 (21.5) 15 (14.0) 14 (13.1) 1 (0.9) 9 (8.4) 6 (5.6) 3 (2.8)
Gentamicin 43 (40.2) 19 (17.8) 24 (22.4) 3 (2.8) 3 (2.8) 0 (0) 61 (57.0) 58 (54.2) 3 (2.8)
 
ESBL: extended-spectrum beta-lactamases.
a The Providencia rettgeri and the Serratia marcescens isolates were excluded because of their natural resistance to colistin.






















Sequence types represented among OXA-48-producing Klebsiella pneumoniae isolates, 2001–11 (n=67)
Figure 2




















(E. cloacae isolate no. 4 and E. coli isolate no. 17, recov-
ered from the same patient), a new Tn1999 derivative 
was identified. This new transposon Tn1999.4 was 
composed of Tn1999.2 disrupted by another transpo-
son, Tn2015 which, in turn, was composed of ISEcp1, 
blaCTX-M-15 and a truncated Tn2 transposase [32]. 
Discussion
We have analysed here many different features of 107 
known OXA-48-positive enterobacterial isolates which 
are widely distributed at least in several European 
and North African countries, and also in Turkey. 
Noticeably, 25% of the OXA-48 beta-lactamase produc-
ers remained susceptible to broad-spectrum cephalo-
sporins, which therefore present possible therapeutic 
options. At least positive therapeutic outcomes have 
been obtained using an animal model of infection and 
broad-spectrum cephalosporins [33]. Those ESBL-
negative isolates were most often susceptible to the 
other classes of antibiotics, which is in line with the 
fact that the epidemic plasmid encoding the blaOXA-48 
gene does not carry additional resistance determinants 
[28].
However, 75% of the OXA-48-positive isolates in our 
study harboured an additional ESBL-encoding gene 
that confers resistance to broad-spectrum cephalo-
sporins. We have recently reported the genetic asso-
ciation of the blaCTX-M-15 and blaOXA-48 genes on the same 
transposon, indicating that this combination of multid-
rug-resistance genes may spread further in the future 
[32]. In addition, most of those ESBL-producing isolates 
were resistant to non-beta-lactam antibiotics, due to 
other resistance mechanisms. It is worth mentioning 
that 70 isolates (65%) were susceptible to imipenem 
and meropenem according to CLSI guidelines, further 
complicating the detection of OXA-48-producing iso-
lates in laboratories. Conversely, most isolates showed 
intermediate susceptibility or resistance to ertapenem. 
Ertapenem  may thus be the most appropriate car-
bapenem molecule for detecting OXA-48 producers. 
Therefore, a selective medium containing ertapenem 
has recently been developed for the detection of all 
types of carbapenemase producers including the OXA-
48 beta-lactamase producers [34]. Taking into account 
the fact that 75% of the OXA-48 isolates were ESBL pro-
ducers and the level of resistance to non-beta-lactam 
molecules, treatment options for infections caused by 
OXA-48 beta-lactamase producers may be limited. The 
efficacy of carbapenems in treating infections due to 
OXA-48 beta-lactamase producers with susceptibility 
or low-level resistance to several carbapenems remains 
debatable, because carbapenems have been shown to 
be an inefficient therapy for treating mice with induced 
peritonitis caused by an OXA-48-producing K. pneumo-
niae [33]. Also, imipenem-containing therapy failed to 
treat several OXA-48 infections in humans [4,11]. A sin-
gle report described imipenem as efficient treatment 
against bacteraemia due to an OXA-48 K. pneumoniae 
isolate [35]. Controlled trials are needed to evaluate 
the real clinical efficacy of carbapenems in treating 
infections due to OXA-48 beta-lactamase producers.
The clonal distribution of OXA-48 beta-lactamase-
positive isolates is interesting because a quarter of 
the K. pneumoniae isolates belonged to ST101. OXA-
48-positive K. pneumoniae isolates belonging to 
ST101 have recently been implicated in an outbreak in 
Spain, and have also been detected in Tunisia [11,12]. 
We report here that the ST101 isolates were recovered 
from Tunisia, Morocco, and from South Africa and 
France from patients who did not travel abroad, sug-
gesting that this ST has now widely spread in European 
countries and in Africa. Seven K. pneumoniae isolates 
belonged to ST395, a ST implicated in clonal outbreaks 
in Europe [11,14]. Interestingly, we detected seven ST15 
among K. pneumoniae isolates recovered from patients 
who had a link with Morocco. That sequence type cor-
responds to an internationally occurring clone and 
has been associated with different ESBL genes, but 
also with the metallo-beta-lactamase genes coding for 
NDM and VIM [36,37]. The occurrence of OXA-48 beta-
lactamase in a ST15 K. pneumoniae isolate had been 
reported only once, in 2012, in an isolate from Finland 
[38]. Those data are likely to indicate that a novel OXA-
48 K. pneumoniae clone belonging to ST15 may emerge 
in Morocco. K. pneumoniae isolates belonging either to 
ST392 or ST147 (differing at a single locus) were iden-
tified in a total of eight isolates, with the two ST392 
collected in Morocco and the six ST147 collected in 
Belgium, Turkey and France, and also from patients 
originating from Tunisia or Libya. This result highlights 
the dissemination of another OXA-48-producing clone, 
mainly in the Mediterranean area. The other K. pneu-
moniae isolates belonged to diverse ST, supporting 
the hypothesis of the widespread dissemination of a 
single blaOXA-48-positive IncL/M plasmid among vari-
ous genetic backgrounds. Overall, there is no associa-
tion between ST type and ESBL type among OXA-48 
producers.
Among the 24 E. coli isolates, seven were of ST38, show-
ing that this clone is widely disseminated, as previously 
suggested [7,39]. Interestingly, the blaOXA-48 gene was 
chromosomally located in six of those isolates, as was 
speculated for the ST38 E. coli isolates recovered in the 
United Kingdom [7]. Such chromosomal location of the 
blaOXA-48 gene in E. coli may be associated to a lower 
level of resistance (a single gene copy). The other 17 E. 
coli isolates were genetically distinct. Furthermore, it 
is interesting to note that 16 of the 24 OXA-48-positive 
E. coli belonged to phylogenetic group D or B2, which 
mainly include virulent strains. The E. cloacae isolates 
were overall clonally diverse. 
As suggested previously, the blaOXA-48 gene was located 
on a 62 kb IncL/M plasmid in most of our isolates (n=99, 
92.5%), indicating that current spread of OXA-48 beta-
lactamase producers is mainly related to the diffusion 
of this plasmid. The dissemination of the blaOXA-48 gene 
is also associated with the spread of different clones. 
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Interestingly, 20% of OXA-48-producing isolates col-
lected in France were considered to be autochthonous, 
indicating that the blaOXA-48 gene has already spread in 
the community in France. This latter result indicates 
ongoing diffusion of OXA-48-type genes in Europe.
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